Piclamilast Uses, Dosage, Side Effects and more
Piclamilast (RP-73,401), is a selective PDE4 inhibitor comparable to other PDE4 inhibitors for its anti-inflammatory effects. It has been investigated for its applications to the treatment of conditions such as chronic obstructive pulmonary disease, bronchopulmonary dysplasia and asthma. The structure for piclamilast was first elucidated in a 1995 European patent application and exhibits the structural functionalities of cilomilast and roflumilast.
| Trade Name | Piclamilast |
| Generic | Piclamilast |
| Piclamilast Other Names | Piclamilast, Piclamilastum |
| Type | |
| Formula | C18H18Cl2N2O3 |
| Weight | Average: 381.253 Monoisotopic: 380.069447866 |
| Groups | Experimental |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
